Change in the growth rate of localized pancreatic adenocarcinoma in response to gemcitabine, bevacizumab, and radiation therapy on MDCT.
Int J Radiat Oncol Biol Phys
; 81(2): 452-9, 2011 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-21570199
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Carcinoma, Pancreatic Ductal
/
Tumor Burden
Type of study:
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2011
Type:
Article